Sarcopenia is a predictor for Alzheimer’s continuum and related clinical outcomes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Sarcopenia is a predictor for Alzheimer’s continuum and related clinical outcomes ; volume:14 ; number:1 ; day:10 ; month:9 ; year:2024 ; pages:1-8 ; date:12.2024
Scientific reports ; 14, Heft 1 (10.9.2024), 1-8, 12.2024
- Creator
-
Kim, Jeonghun
Suh, Sang-Il
Park, Yu Jeong
Kang, Minwoong
Chung, Su Jin
Lee, Eun Seong
Jung, Hye Na
Eo, Jae Seon
Koh, Seong-Beom
Oh, Kyungmi
Kang, Sung Hoon
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-62918-y
- URN
-
urn:nbn:de:101:1-2411242100534.287316599240
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kim, Jeonghun
- Suh, Sang-Il
- Park, Yu Jeong
- Kang, Minwoong
- Chung, Su Jin
- Lee, Eun Seong
- Jung, Hye Na
- Eo, Jae Seon
- Koh, Seong-Beom
- Oh, Kyungmi
- Kang, Sung Hoon
- SpringerLink (Online service)
Other Objects (12)
Glial activation and inflammation along the Alzheimer’s disease continuum
The dynamics of plasma biomarkers across the Alzheimer’s continuum
Melatonin levels in the Alzheimer’s disease continuum: a systematic review
On the path to 2025: understanding the Alzheimer’s disease continuum
Memory markers in the continuum of the Alzheimer’s clinical syndrome
Neuropathology of the Alzheimer's continuum: an update
Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
Alterations in resting-state network dynamics along the Alzheimer’s disease continuum
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum
Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum
Glial activation and inflammation along the Alzheimer’s disease continuum
The dynamics of plasma biomarkers across the Alzheimer’s continuum
Melatonin levels in the Alzheimer’s disease continuum: a systematic review
On the path to 2025: understanding the Alzheimer’s disease continuum
Memory markers in the continuum of the Alzheimer’s clinical syndrome
Neuropathology of the Alzheimer's continuum: an update
Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
Alterations in resting-state network dynamics along the Alzheimer’s disease continuum
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum
Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum
Glial activation and inflammation along the Alzheimer’s disease continuum
The dynamics of plasma biomarkers across the Alzheimer’s continuum
Melatonin levels in the Alzheimer’s disease continuum: a systematic review
On the path to 2025: understanding the Alzheimer’s disease continuum
Memory markers in the continuum of the Alzheimer’s clinical syndrome
Neuropathology of the Alzheimer's continuum: an update
Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
Alterations in resting-state network dynamics along the Alzheimer’s disease continuum
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum